Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Packer

Showing results (241-250 of 4,797) with videos related to

Pageof 480
Sort By:
Circulation|May 9, 2018
The Alchemist's Nightmare: Might Mesenchymal Stem Cells That Are Recruited to Repair the Injured Heart Be Transformed Into Fibroblasts Rather Than Cardiomyocytes?Milton Packer
JACC. Heart Failure|December 30, 2017
Acute Heart Failure Is an Event Rather Than a Disease: Plea for a Radical Change in Thinking and in Therapeutic Drug DevelopmentMilton Packer
JACC. Heart Failure|November 11, 2019
HFpEF Is the Substrate for Stroke in Obesity and Diabetes Independent of Atrial FibrillationMilton Packer
Drugs|January 1, 1986
The role of vasodilator therapy in the treatment of severe chronic heart failureM Packer
The American Journal of Medicine|January 9, 2018
Is the Popularity of Dipeptidyl-Peptidase-4 Inhibitors Justified? Insights From Mechanistic Studies and Clinical TrialsMilton Packer
Diabetes, Obesity & Metabolism|January 10, 2018
Have we really demonstrated the cardiovascular safety of anti-hyperglycaemic drugs? Rethinking the concepts of macrovascular and microvascular disease in type 2 diabetesMilton Packer
European Journal of Heart Failure|March 23, 2018
Are the effects of drugs to prevent and to treat heart failure always concordant? The statin paradox and its implications for understanding the actions of antidiabetic medicationsMilton Packer
European Journal of Heart Failure|December 19, 2018
The conundrum of patients with obesity, exercise intolerance, elevated ventricular filling pressures and a measured ejection fraction in the normal rangeMilton Packer
International Journal of Cardiology|March 18, 2018
Inferential characterization of the dose-response relationships of neurohormonal antagonists in chronic heart failure: A novel approach based on large-scale trials with active comparatorsMilton Packer
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|March 1, 1987
Resident training in chronic care and rehabilitationS Packer
Pageof 480

Showing results (241-250 of 4,797) with videos related to

Sort By:
Pageof 480
Circulation|May 9, 2018
The Alchemist's Nightmare: Might Mesenchymal Stem Cells That Are Recruited to Repair the Injured Heart Be Transformed Into Fibroblasts Rather Than Cardiomyocytes?Milton Packer
JACC. Heart Failure|December 30, 2017
Acute Heart Failure Is an Event Rather Than a Disease: Plea for a Radical Change in Thinking and in Therapeutic Drug DevelopmentMilton Packer
JACC. Heart Failure|November 11, 2019
HFpEF Is the Substrate for Stroke in Obesity and Diabetes Independent of Atrial FibrillationMilton Packer
Drugs|January 1, 1986
The role of vasodilator therapy in the treatment of severe chronic heart failureM Packer
The American Journal of Medicine|January 9, 2018
Is the Popularity of Dipeptidyl-Peptidase-4 Inhibitors Justified? Insights From Mechanistic Studies and Clinical TrialsMilton Packer
Diabetes, Obesity & Metabolism|January 10, 2018
Have we really demonstrated the cardiovascular safety of anti-hyperglycaemic drugs? Rethinking the concepts of macrovascular and microvascular disease in type 2 diabetesMilton Packer
European Journal of Heart Failure|March 23, 2018
Are the effects of drugs to prevent and to treat heart failure always concordant? The statin paradox and its implications for understanding the actions of antidiabetic medicationsMilton Packer
European Journal of Heart Failure|December 19, 2018
The conundrum of patients with obesity, exercise intolerance, elevated ventricular filling pressures and a measured ejection fraction in the normal rangeMilton Packer
International Journal of Cardiology|March 18, 2018
Inferential characterization of the dose-response relationships of neurohormonal antagonists in chronic heart failure: A novel approach based on large-scale trials with active comparatorsMilton Packer
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|March 1, 1987
Resident training in chronic care and rehabilitationS Packer
Pageof 480